7月31日 - ** 制药公司百健BIIB.O盘前股价上涨5.8%至134美元
** 公司提高了 (link)，2025年调整后每股 利润介于15.50美元至16.00美元之间，此前预期为14.50美元至15.50美元。
** 分析师预计 2025 年每股利润为 14.68 美元
** 公司公布第二季度销售额为26亿美元，高于分析师预计的23.2亿美元 - LSEG数据
** 公司公布第二季度利润为5.47美元/股，高于预期的3.86美元/股
** 截至上次收盘，股价累计下跌 17
(为便利非英文母语者，路透将其报导自动化翻译为数种其他语言。由于自动化翻译可能有误，或未能包含所需语境，路透不保证自动化翻译文本的准确性，仅是为了便利读者而提供自动化翻译。对于因为使用自动化翻译功能而造成的任何损害或损失，路透不承担任何责任。)
Disclaimer: Investing carries risk. This is not financial advice. The above content should not be regarded as an offer, recommendation, or solicitation on acquiring or disposing of any financial products, any associated discussions, comments, or posts by author or other users should not be considered as such either. It is solely for general information purpose only, which does not consider your own investment objectives, financial situations or needs. TTM assumes no responsibility or warranty for the accuracy and completeness of the information, investors should do their own research and may seek professional advice before investing.